Weekly Pill Offers New Hope for HIV | UK News

A groundbreaking once-a-week HIV pill, combining Islatravir and Lenacapavir, is proving just as effective as daily regimens—and could transform lives by reducing the mental burden and stigma tied to constant medication. Results from a global trial of 600+ participants show promise, with long-term monitoring ongoing. For many, like Stephen Hart, this shift means less daily reminder of their condition and greater dignity. While yearly injections offer another option, the weekly pill provides unmatched flexibility—especially for those managing multiple health needs or facing social stigma. As science advances, so too must societal attitudes, but this new treatment offers real hope for improved adherence and quality of life. Listen in comfort:Get a discount on a Soli Pillow: http://solipillow.com/discount/dnn. Advertise on DNN:[email protected] This is an automated, high-level news summary based on public reporting.Report issues to [email protected]. View sources & latest updates:https://sources.thednn.ai/828eb41bd888de2e